Search Results - Guobao Zhang
- Showing 1 - 3 results of 3
-
1
Expanding the Diversity of Allosteric Bcr-Abl Inhibitors by Xianming Deng, Okram Barun, Qiang Ding, Jianming Zhang, Yongmun Choi, Francisco Adrián, Amy Wojciechowski, Guobao Zhang, Jianwei Che, Badry Bursulaya, Sandra W. Cowan‐Jacob, Gabriele Rummel, Taebo Sim, Nathanael S. Gray
Published 2010Artigo -
2
Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors by Cheng Dai, Jun Liu, Dong Han, Guobao Zhang, Wenqi Gao, Mindy H. Hsieh, Nicholas Ng, Shailaja Kasibhatla, Celin Tompkins, Jie Li, Auzon Steffy, Fangxian Sun, Chun Li, H. Martin Seidel, Jennifer L. Harris, Shifeng Pan
Published 2016Artigo -
3
A Type-II Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of Bcr-Abl by Hwan Geun Choi, Pingda Ren, Francisco Adrián, Fangxian Sun, Hyun Soo Lee, Xia Wang, Qiang Ding, Guobao Zhang, Yongping Xie, Jianming Zhang, Yi Liu, Tove Tuntland, Markus Warmuth, Paul W. Manley, Jürgen Mestan, Nathanael S. Gray, Taebo Sim
Published 2010Artigo
Search Tools:
Related Subjects
Biochemistry
Biology
Cancer research
Chemistry
Imatinib
Kinase
Myeloid leukemia
Pharmacology
Receptor
Signal transduction
Acetamide
Allosteric regulation
Binding site
Bioavailability
Blockade
Bosutinib
Computational biology
Dasatinib
Drug discovery
Enzyme
Gene
Imatinib mesylate
In vitro
K562 cells
Luciferase
Mutant
Nilotinib
Organic chemistry
Small molecule
Structure–activity relationship